|
|
|
|
Low-Fat Diet May Not Reduce Cardio Risks After Menopause
FRIDAY, March 19 (HealthDay News) -- In postmenopausal women, a low-fat diet has little effect on cardiovascular risk factors and no overall effect on coronary heart disease and stroke, according to a study published online Feb.17 in the American...
|
|
|
Johnson and Johnson (JNJ) PriceWatch Alert For 3/19/2010 - Calendar Spread Risk Ranking Improves to 4 Keys
Johnson and Johnson (NYSE: JNJ) closed yesterday at $65.06.So far the stock has hit a 52-week low of $49.49 and 52-week high of $65.95. The proprietary Key Risk Ranking for JNJ has improved from a 3 KEY Moderate Relative Risk to a 4 KEY Low...
|
|
|
Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
New Data From Second Phase Shows No Blood Clots, No Repeat Procedures and Very Low MACE in Patients Treated with Abbotts Innovative Device ATLANTA Abbott (NYSE: ABT) today announced positive 30-day results from the first 101 patients enrolled in the...
|
|
|
Poorer girls not getting HPV vaccine for cervical cancer
A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.Mississippi and Arkansas, two of the nation's poorest states, also have the highest death rates from cervical cancer a result of poor access to basic...
|
|
|
Dabigatran etexilate shows greater reductions than warfarin in stroke in patients with atrial fibrillation acr
- Compared to well-controlled warfarin, dabigatran etexilate provided consistent benefits in stroke prevention in atrial fibrillation (AF), irrespective of a patient's risk profile for stroke(1) - Dabigatran etexilate 150mg bid reduced the number of strokes in...
|
|
|
Medical News: PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin
PolyMedix, Inc.(OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B clinical study to evaluate the safety and efficacy of PMX...
|
|
|
PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin
PolyMedix, Inc.(OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B clinical study to evaluate the safety and efficacy of PMX...
|
|
|
Poorer Girls Not Getting HPV Vaccine For Cervical Cancer
(USA TODAY) -- A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.Mississippi and Arkansas, two of the nation's poorest states, also have the highest death rates from cervical cancer - a result of poor...
|
|
|
Value of Low-Field Magnetic Resonance Imaging in Diagnosing Meniscal Tears in the Canine Stifle: A Prospective Study Evaluating Sensitivity and Specificity in Naturally Occurring Cranial Cruciate Ligament Deficiency with Arthroscopy as the Gold Standard
To evaluate the sensitivity and specificity of low-field magnetic resonance imaging (lfMRI) for detection of meniscal tears in the canine stifle.Double-blinded prospective clinical study. Forty-two consecutive stifles of dogs ([ge]20 kg; n=34) with...
|
|
|
Risk of TB Transmission During Air Travel Is Deemed Low
FRIDAY, March 19 (HealthDay News) -- There is low risk of tuberculosis (TB) being transmitted between airline passengers, and, contrary to current World Health Organization guidelines, tracing and screening airline passengers who may have been exposed to...
|
|
|
Kidney Injury From Contrast Media Appears Low: Presented at ACC
-- The risk of suffering acute kidney injury from exposure to iodinated contrast media appears to be very low, with few differences noted between the 3 most commonly used low-osmolar formulations, according to a study here at the 59th Annual...
|
|
|
Higher Rates of Asthma Among Kids Linked to Low Vitamin D Levels
Child Health News Font Size Researchers have said that African American children with asthma in metropolitan Washington, DC, are significantly more likely to have low levels of vitamin D than healthy African American children.The study by researchers...
|
|
|
Low-risk group has high prevalence of abnormal ankle-brachial index
NEW YORK (Reuters Health) - A screening population without cardiovascular disease or diabetes had roughly a 14% prevalence of abnormal ankle-brachial index (ABI), investigators reported this week.Many of those with an abnormal ABI were categorized as "low...
|
|
|
HPV testing during smear tests not a useful predictor for cancer
Routine testing for the human papilloma virus (HPV) as part of the Cervical Screening Programme does not help doctors identify which women are at risk of cancer or the best form of follow-up treatment, according to new research funded by the Medical Research...
|
|
|
Effects of low fat vs. moderate fat diets on insulin resistance, endothelial function
American College of Cardiology 59th Annual Scientific Session ATLANTA - A moderate-fat diet improved the atherogenic dyslipidemia of metabolic syndrome over a low-fat diet, but there was little contrast between the two diets in terms of the effect on...
|
|
|
Effects of low fat vs. moderate fat diets on insulin resistance, endothelial function
ATLANTA A moderate-fat diet improved the atherogenic dyslipidemia of metabolic syndrome over a low-fat diet, but there was little contrast between the two diets in terms of the effect on insulin resistance or endothelial function.One of the big...
|
|
|
Elder Pharma ups stake in Bulgarian arm to 61 pct
How to save your taxes and manage your investments The company aims to capitalise on the low infrastructure and production costs existing in EU & CIS markets.Elder Pharmaceuticals Limited has hiked stake in its Bulgarian subsidiary Elder Biomeda AD...
|
|
|
Bone/Osteoporosis/Vitamin D CROI 2010 Update
17th CROI Conference on Retroviruses and Opportunistic Infections San Francisco CA February 16-19, 2010 Michael Yin, MD MS Assistant Professor of Clinical Medicine Columbia University Medical Center New York, NY Osteoporosis is defined in the article in this...
|
|
|
PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin
PMX-60056 is the first ever agent taken into clinical trials for LMWH reversal RADNOR, Pa.(BUSINESS WIRE) PolyMedix, Inc.(OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...
|
|
|
Poorer Girls Not Getting HPV Vaccine for Cervical Cancer
A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.Mississippi and Arkansas, two of the nation's poorest states, also have the highest death rates from cervical cancer - a result of poor access to basic...
|
|
|
Low-cost insurance policies aim to prevent poverty among small-scale farmers in Kenya
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.While crop insurance is widely used in the developed world, cost has been a...
|
|
|
PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin
Let the jobs come to you!PolyMedix, Inc! (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B clinical study to evaluate the...
|
|
|
Poorer girls not getting HPV vaccine for cervical cancer
A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.FDA: OKs Gardasil for boys CDC: 1 in 3 teen girls got cervical cancer vaccine FORUM: Living with Cancer Mississippi and Arkansas, two of the nation's...
|
|
|
AstraZeneca (AZN) PriceWatch Alert - Covered Call Risk Ranking Declines to 3 Keys
AstraZeneca (NYSE: AZN) closed yesterday at $44.71.So far the stock has hit a 52-week low of $32.22 and 52-week high of $50.70. The proprietary Key Risk Ranking for AZN has declined from a 4 KEY Low Relative Risk to a 3 KEY Moderate Relative...
|
|
|
Rosuvastatin Reduces Risk of Death in Patients With CKD, Elevated C-Reactive Protein: Presented at ACC
-- Patients with chronic kidney disease (CKD) who have low levels of cholesterol but elevated C-reactive protein appear to markedly reduce their risk of mortality when treated with rosuvastatin, researchers said here at the 59th Annual Scientific Sessions...
|
